Synergic chemoprevention with dietary carbohydrate restriction and supplementation of AMPK-activating phytochemicals: The role of SIRT1

European Journal of Cancer Prevention

Volumn 25, Issue 1, 2016, Pages 54-64

  Lee, Jong Doo ^a,b   Choi, Min Ah ^b   Ro, Simon Weonsang ^b,c   Yang, Woo Ick ^b,d   Cho, Arthur E H ^b   Ju, Hye Lim ^b,c   Baek, Sinhwa ^b,c   Chung, Sook In ^b,c   Kang, Won Jun ^b   Yun, Mijin ^b   Park, Jeon Han ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Department of Nuclear Medicine ^*  (South Korea)

^c Liver Cirrhosis Clinical Research Centre   (South Korea)

^d Catholic Kwandong University   (South Korea)

Author keywords

carbohydrate restriction; Chemoprevention; Energy metabolism; Liver cancer; Melanoma; Phytochemical; SIRT1

Indexed keywords

CARBOHYDRATE; CATECHIN; CURCUMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; PROTEIN KINASE LKB1; QUERCETIN; RESVERATROL; SIRTUIN 1; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR FKHRL1; CARBOHYDRATE DIET; SIRT1 PROTEIN, MOUSE; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALORIC RESTRICTION; CANCER INHIBITION; CANCER PREVENTION; CANCER THERAPY; CARBOHYDRATE DIET; CELL PROLIFERATION; CONTROLLED STUDY; DIET RESTRICTION; ENERGY METABOLISM; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; HISTONE METHYLATION; HUMAN; HUMAN CELL; HYDRODYNAMICS; LIVER CANCER; LIVER CELL; LOW CARBOHYDRATE DIET; MALE; MELANOMA; MELANOMA CELL LINE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL; SURVIVAL TIME; ADMINISTRATION AND DOSAGE; ANIMAL; C57BL MOUSE; CHROMATIN IMMUNOPRECIPITATION; DIETARY SUPPLEMENT; DNA MICROARRAY; DRUG EFFECTS; DRUG POTENTIATION; GENETICS; LIVER NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; METABOLISM; MORTALITY; PATHOLOGY; PHARMACOLOGY; PHOSPHORYLATION; SURVIVAL RATE; TRANSGENIC MOUSE; TUMOR CELL CULTURE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BIOMARKERS, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DIETARY CARBOHYDRATES; DIETARY SUPPLEMENTS; DRUG SYNERGISM; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PHYTOCHEMICALS; SIGNAL TRANSDUCTION; SIRTUIN 1; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 84948676244     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000141     Document Type: Article

References (54)

1. Bernier M, Paul RK, Martin-Montalvo A, Scheibye-Knudsen M, Song S, He HJ, et al. (2011). Negative regulation of STAT3 protein-mediated cellular respiration by SIRT1 protein. J Biol Chem 286:19270-19279.
2. Bost F, Sahra IB, Marchand-Brustel YL, Tanti JF (2012). Metformin and cancer therapy. Curr Opin Oncol 24:103-108.
3. Bravata DM, Sanders L, Huang J, Krumholz HM, Olkin I, Gardner CD, et al. (2003). Efficacy and safety of low-carbohydrate diets. A systemic review. JAMA 289:1837-1850.
4. Calnan DR, Brunet A (2008). The FoxO code. Oncogene 27:2276-2288.
5. Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, et al. (2009). AMPK regulates energy expenditure by modulating NAD + metabolism and SIRT1 activity. Nature 458:1056-1060.
6. Cheong JH, Park ES, Liang J, Dennison JB, Tsavachidou D, Nguyen-Charles C, et al. (2011). Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models. Mol Cancer Ther 10:2350-2362.
7. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I (2010). Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 501:79-90.
8. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, et al. (2009). Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325:201-204.
9. Czabotar PE, Colman PM, Huang DCS (2009). Bax activation by Bim? Cell Death Differ 16:1187-1191.
10. Dasgupta B, Milbrandt J (2007). Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A 104:7217-7222.
11. Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R, Barrett JC (1997). Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57:4667-4672.
12. El Mjiyad N, Caro-Maldonado A, Ramírez-Peinado S, Muñoz-Pinedo C (2011). Sugar-free approaches to cancer cell killing. Oncogene 30:253-264.
13. Ghosh AK, Kay NE, Secreto CR, Shanafelt TD (2009). Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Clin Cancer Res 15:1250-1258.
14. Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP, Brunet A (2007). The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 282:30107-30119.
15. Herranz D, Serrano M (2010). SIRT1: recent lessons from mouse models. Nat Rev Cancer 10:819-823.
16. Ho VW, Leung K, Hsu A, Luk B, Lai J, Shen SY, et al. (2011). A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. Cancer Res 71:4484-4493.
17. Ju HL, Ahn SH, Kim do Y, Baek S, Chung SI, Seong J, et al. (2013). Investigation of oncogenic cooperation in simple liver-specific transgenic mouse models using noninvasive in vivo imaging. PLoS One 8:e59869.
18. Jung JH, Lee JO, Kim JH, Lee SK, You GY, Park SH, et al. (2010). Quercetin suppresses HeLa cell viability via AMPK-induced HSP70 and EGFR downregulation. J Cell Physiol 223:408-414.
19. Khodadoust MS, Verhaegen M, Kappes F, Riveiro-Falkenbach E, Cigudosa JC, Kim DS, et al. (2009). Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Res 69:6405-6413.
20. Konson A, Pradeep S, Seger R (2010). Phosphomimetic mutants of pigmented epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents. Cancer Res 70:6247-6257.
21. Lan F, Cacicedo JM, Ruderman N, Ido Y (2008). SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 283:27628-27635.
22. Last AR, Wilson SA (2006). Low-carbohydrate diets. Am Fam Physician 73:1942-1948.
23. Lee CW, Wong LL, Tse EY, Liu HF, Leong VY, Lee JM, et al. (2012). AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. Cancer Res 72:4394-4404.
24. Lee M, Vasioukhin V (2008). Cell polarity and cancer -cell and tissue polarity as a non-canonical tumor suppressor. J Cell Sci 121 (Pt 8):1141-1150.
25. Levine AJ, Puzio-Kuter AM (2010). The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330:1340-1344.
26. Levy C, Khaled M, Fisher DE (2006). MITF; master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12:406-414.
27. Li Y, Liu L, Tollefsbol TO (2010). Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J 24:1442-1453.
28. Link A, Balaguer F, Goel A (2010). Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 80:1771-1792.
29. Liu RH (2004). Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134 (Suppl):3479S-3485S.
30. Liu T, Liu PY, Marshall GM (2009). The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res 69:1702-1705.
31. López-Lázaro M (2008). The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med Chem 8:305-312.
32. Luo Z, Zang M, Guo W (2010). AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol 6:457-470.
33. Masko EM, Thomas JA, Antonelli JA, Lloyd JC, Phillips TE, Poulton SH, et al. (2010). Low-carbohydrate diets and prostate cancer: how low is 'low enough'? Cancer Prev Res 3:1124-1131.
34. Mattison JA, Roth GS, Beasley TM, Tilmont EM, Handy AM, Herbert RL, et al. (2012). Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 489:318-321.
35. Menendez JA, Oliveras-Ferraros C, Cufí S, Corominas-Faja B, Joven J, Martin-Castillo R, et al. (2012). Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle 11:2782-2792.
36. Nayagam VM, Wang X, Tan YC, Poulsen A, Goh KC, Ng T, et al. (2006). SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents. J Biomol Screen 11:959-967.
37. Nemoto S, Fergusson MM, Finkel T (2004). Nutrition availability regulates SIRT1 through a forkhead-dependent pathway. Science 306:2105-2108.
38. Pan W, Yang H, Cao C, Song X, Wallin B, Kivlin R, et al. (2008). AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells. Oncol Rep 20:1553-1559.
39. Park IJ, Lee YK, Hwang JT, Kwon DY, Ha J, Park OJ (2009). Green tea catechin controls apoptosis in colon cancer cells by attenuation of H2O2-stimulated COX-2 expression via the AMPK signaling pathway at low-dose H2O2.. Ann N Y Acad Sci 1171:538-544.
40. Peters JM, Shah YM, Gonzalez FJ (2012). The role of peroxisome proliferatoractivated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer 12:181-195.
41. Ricciardiello L, Bazzoli F, Fogliano V (2011). Phytochemicals and colorectal cancer prevention -myth or reality? Nat Rev Gastroenterol Hepatol 8:592-596.
42. Roth M, Chen WY (2013). Sorting out functions of sirtuins in cancer. Oncogene 33:1609-1620.
43. Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y (2010). AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 298:E751-E760.
44. Scott EN, Gescher AJ, Steward WP, Brown K (2009). Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials. Cancer Prev Res (Phila) 2:525-530.
45. Sebastian S, Kenkare UW (1997). Insulin-like growth factor I induces tumor hexokinase RNA expression in cancer cells. Biochem Biophys Res Commun 235:389-393.
46. Seyfried TN, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P (2012). Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer? Epilepsy Res 100:310-326.
47. Seymour EM, Bennink MR, Watts SW, Bolling SF (2010). Whole grape intake impacts cardiac peroxisome proliferator-activated receptor and nuclear factor kappaB activity and cytokine expression in rats with diastolic dysfunction. Hypertension 55:1179-1185.
48. Shackelford DB, Shaw RJ (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9:563-575.
49. Sun Q, Chen X, Ma J, Peng H, Wang F, Zha X, et al. (2011). Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci U S A 108:4129-4134.
50. Surh YJ (2003). Cancer chemoprevention with dietary phyrochemicals. Nat Rev 3:768-780.
51. Wellen KE, Lu C, Mancuso A, Lemons JM, Ryczko M, Dennis JW, et al. (2010). The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev 24:2784-2799.
52. Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P, Zhang Y (2001). Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 8:1207-1217.
53. Yang J, Splittgerber R, Yull FE, Kantrow S, Ayers GD, Karin M, Richmond A (2010). Conditional ablation of Ikkb inhibits melanoma tumor development in mice. J Clin Invest 120:2563-2574.
54. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369-2380.